AI and Healthcare
xCures
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.
This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
This series caters to anyone’s listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and VP of Clinical AI at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
Originally launched as the TARGET: Cancer Podcast in 2021, the series evolved after 75 episodes into a comprehensive platform for AI and healthcare conversations.
Episodes
Mentioned books
Mar 19, 2025 • 43min
Cracking AI in Healthcare: Real Use Cases & Missed Opportunities—with Mika Newton [Full Podcast]
AI is reshaping healthcare, from clinical workflows to drug discovery and the rise of full-stack biotech companies. But what are the real challenges, and where is AI falling short? Mika Newton sits down with Krish Ramadurai from AIX Ventures to break down the complexities of AI in healthcare, the importance of domain expertise, and the push to automate clinical development. They also discuss how startups can navigate the industry’s regulatory landscape and what investors are looking for in AI-driven healthcare solutions. Whether you're in biotech, investing, or just curious about the future of AI, this discussion offers valuable insights.
Mar 13, 2025 • 56min
Can AI Cure Cancer Before It Starts? Dr. Azra Raza Explains—with Dr. Sanjay Juneja [Full Podcast]
Join Dr. Sanjay Juneja and Columbia University professor Dr. Azra Raza in an in-depth discussion about the transformative potential of AI and technology in early cancer detection. Dr. Raza shares her insights on how continuous monitoring and innovative technologies could find cancer at the 'first cell stage,' long before traditional methods. Learn about her journey from pediatric oncology to establishing one of the richest tissue repositories, and discover how AI-powered implantable devices could revolutionize the future of healthcare. This episode sheds light on the untapped possibilities in proactive cancer care and the critical shift needed to focus on early detection.
Mar 6, 2025 • 11min
Are Current AI Developments Sustainable?—with Mika Newton
This episode features Nigam Shah discussing the sustainability of AI in healthcare, focusing on challenges in development, validation, and regulation. The conversation explores the limitations of current AI models, the evolving role of governance, and the need for localized validation to ensure accuracy and relevance.
Mar 2, 2025 • 38min
Rethinking AI in Healthcare: Insights from Dr. Nigam Shah—with Mika Newton [Full Podcast]
In this episode, Mika Newton speaks with Dr. Nigam Shah, a professor at Stanford and Chief Data Scientist at Stanford Healthcare, about the challenges and opportunities of AI in healthcare. They discuss the sustainability of AI development, the complexities of regulation, and the importance of localized validation. The conversation explores how AI can enhance clinical decision-making, optimize healthcare resources, and expand patient access while addressing barriers in implementation, governance, and data sharing.
Feb 24, 2025 • 46min
Breaking Healthcare’s Bottleneck: AI, Data & Policy Fixes with Bob Battista and Mika Newton - Full Podcast
This podcast episode explores the intersection of AI and healthcare, focusing on drug development, repurposing, and access to medical treatments. Mika Newton speaks with Bob Battista about the challenges of sharing pharmaceutical data, regulatory barriers, and how AI could enhance clinical decision-making. They discuss real-world data, patient knowledge, and the role of technology in optimizing treatment pathways. The conversation also touches on privacy laws, governance, and the potential for AI to empower patients with better access to medical insights. Viewers will gain a deeper understanding of how innovation and policy changes could improve healthcare outcomes.
Feb 18, 2025 • 10min
Who is responsible for AI decisions?—with Mika Newton
Bob Battista, an expert in AI and healthcare, dives into the revolutionary potential of AI in reshaping patient autonomy. He highlights how AI can enhance decision-making by processing vast clinical data, allowing patients to take charge of their health. The conversation addresses critical issues around data sharing and governance, comparing AI in healthcare to self-driving cars. Ultimately, they explore the vital role of improving health literacy to empower patients in navigating AI-driven support for better treatment outcomes.
Feb 14, 2025 • 5min
How is AI Changing Healthcare Decision Making?—with Mika Newton
Mika Newton and Bob Battista dive into how AI is revolutionizing healthcare decision-making. They discuss AI's ability to analyze clinical evidence and personalize treatment recommendations. The conversation highlights the challenges of regulatory restrictions and data silos that hinder progress. They emphasize the importance of accessible data for maximizing AI's potential and explore how adaptable healthcare guidelines can enhance patient outcomes, particularly in oncology.
Feb 10, 2025 • 11min
What is the biggest hurdle in drug repurposing today?—with Mika Newton
Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. They also explore potential policy solutions that could encourage collaboration and make more life-saving treatments accessible to patients.
Feb 3, 2025 • 44min
How AI Screening Is Shaping the Future of Drug Discovery with Tom Neyarapally and Mika Newton
Tom Neyarapally, Founder and CEO at Archetype Therapeutics, and Mika Newton, a notable figure in healthcare innovation, dive into the revolutionary impact of AI on drug discovery. They discuss how machine learning and real-world data are reshaping treatments and reducing costs. The pair emphasizes the importance of collaboration between AI technology and clinical expertise to speed up therapy development. They also tackle challenges such as data access and the need for personalized medication, showcasing a new era of patient-centered approaches.
Jan 26, 2025 • 15min
What’s the future of AI in transforming drug discovery?—with Mika Newton
Tom Neyarapally, an expert in AI-driven drug discovery, shares insights on the groundbreaking role of AI in drug development. He discusses the importance of collaboration between pharmaceutical giants and startups to enhance personalized therapies. Neyarapally emphasizes overcoming data challenges for better patient experiences and the need for accessible datasets for effective AI applications. The conversation also covers economic hurdles in drug discovery and how innovative technologies could make medications more affordable.
